BRPI0910878A2 - formulações de oleossomas de liberação controlada e acabada e método de obtenção das mesmas e de liberação de agente ativo a partir de oleossoma - Google Patents

formulações de oleossomas de liberação controlada e acabada e método de obtenção das mesmas e de liberação de agente ativo a partir de oleossoma

Info

Publication number
BRPI0910878A2
BRPI0910878A2 BRPI0910878A BRPI0910878A BRPI0910878A2 BR PI0910878 A2 BRPI0910878 A2 BR PI0910878A2 BR PI0910878 A BRPI0910878 A BR PI0910878A BR PI0910878 A BRPI0910878 A BR PI0910878A BR PI0910878 A2 BRPI0910878 A2 BR PI0910878A2
Authority
BR
Brazil
Prior art keywords
oleosome
formulations
finished
obtaining
active agents
Prior art date
Application number
BRPI0910878A
Other languages
English (en)
Inventor
Jacob Guth
John Ferguson
Original Assignee
Sembiosys Genetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sembiosys Genetics Inc filed Critical Sembiosys Genetics Inc
Publication of BRPI0910878A2 publication Critical patent/BRPI0910878A2/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14Liposomes; Vesicles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/345Alcohols containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86Polyethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Botany (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BRPI0910878A 2008-04-11 2009-04-10 formulações de oleossomas de liberação controlada e acabada e método de obtenção das mesmas e de liberação de agente ativo a partir de oleossoma BRPI0910878A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7110908P 2008-04-11 2008-04-11
PCT/US2009/002242 WO2009126301A2 (en) 2008-04-11 2009-04-10 Controlled release of active agents from oleosomes

Publications (1)

Publication Number Publication Date
BRPI0910878A2 true BRPI0910878A2 (pt) 2015-10-06

Family

ID=41162461

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0910878A BRPI0910878A2 (pt) 2008-04-11 2009-04-10 formulações de oleossomas de liberação controlada e acabada e método de obtenção das mesmas e de liberação de agente ativo a partir de oleossoma

Country Status (13)

Country Link
US (1) US20110081386A1 (pt)
EP (1) EP2274015A2 (pt)
JP (1) JP2011516548A (pt)
KR (1) KR20100135260A (pt)
CN (1) CN102026663A (pt)
AU (1) AU2009234384A1 (pt)
BR (1) BRPI0910878A2 (pt)
CA (1) CA2720755A1 (pt)
EA (1) EA201071166A1 (pt)
IL (1) IL208481A0 (pt)
MX (1) MX2010011105A (pt)
NZ (1) NZ588441A (pt)
WO (1) WO2009126301A2 (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110742128A (zh) 2011-07-12 2020-02-04 非凡食品有限公司 用于消费品的方法和组合物
US20140220217A1 (en) 2011-07-12 2014-08-07 Maraxi, Inc. Method and compositions for consumables
US10039306B2 (en) 2012-03-16 2018-08-07 Impossible Foods Inc. Methods and compositions for consumables
KR20230022455A (ko) 2011-07-12 2023-02-15 임파서블 푸즈 인크. 소비재를 위한 방법 및 조성물
EP3513664A1 (en) 2013-01-11 2019-07-24 Impossible Foods Inc. Method of producing a flavoured cultured non-dairy product
PL2943078T3 (pl) 2013-01-11 2021-09-20 Impossible Foods Inc. Sposoby wytwarzania i kompozycje produktów konsumpcyjnych
US10172380B2 (en) 2014-03-31 2019-01-08 Impossible Foods Inc. Ground meat replicas
CN105311037B (zh) * 2014-07-31 2018-04-17 山东达因海洋生物制药股份有限公司 一种维生素d胶囊型滴剂及其制备方法
PL3362151T3 (pl) 2015-10-15 2020-11-30 Cargill, Incorporated Kompozycja zawierająca oleosomy o różnym rozkładzie wielkości
WO2017177334A1 (en) 2016-04-15 2017-10-19 Botaneco Inc. Sunscreen formulations comprising an oleosome suspension and an acidic buffering system
US11591540B2 (en) 2017-12-22 2023-02-28 Time-Travelling Milkman B.V. Method for the preparation of dried oleosomes
US20220073443A1 (en) * 2018-12-21 2022-03-10 Botaneco Inc. Cannabinoid formulations and methods of making same
EP4075992A1 (en) * 2019-12-16 2022-10-26 Cargill, Incorporated Isolated oleosome composition and process for preparing it
KR102686213B1 (ko) * 2022-06-07 2024-07-19 (주)삼경코스텍 분지형 다이올계 화합물을 유효성분으로 포함하는 우수한 안정성 및 항균성을 지닌 올레오좀 제제 조성물 및 이의 제조방법
WO2024030870A1 (en) * 2022-08-04 2024-02-08 Archer Daniels Midland Company Stable oleosome preparation for edible applications

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE386439T1 (de) * 1997-05-27 2008-03-15 Sembiosys Genetics Inc Verwendungen von ölkörpern
US6372234B1 (en) * 1997-05-27 2002-04-16 Sembiosys Genetics Inc. Products for topical applications comprising oil bodies
US20040081654A1 (en) * 2000-06-16 2004-04-29 Schryvers Anthony B Use of plant oil-bodies in vaccine delivery systems
EA009181B1 (ru) * 2000-12-19 2007-12-28 Сембайосиз Джинетикс, Инк. Рекомбинантные мультимерные белковые комплексы, связанные с масляными тельцами, способы получения указанных комплексов и масляных телец и содержащие их продукты и композиции
ATE327006T1 (de) * 2001-03-23 2006-06-15 Oreal Hautbehandlungsmittel enthaltend fasern und ubichinone
US20060179514A1 (en) * 2001-07-05 2006-08-10 Sembiosys Genetics, Inc. Methods for the production of multimeric protein complexes, and related compositions
FR2833171B1 (fr) * 2001-12-07 2004-02-13 Codif Internat Sa Produit cosmetique/dermatologique a base d'emulsion triple
EP1670434A4 (en) * 2003-10-02 2010-06-23 Sembiosys Genetics Inc PROCESSES FOR PREPARING OILY BODIES COMPRISING ACTIVE INGREDIENTS
ITBO20050388A1 (it) * 2005-06-06 2006-12-07 Alfa Wassermann Spa Formulazione mucoadesive utili in dispositivi medici in preparazioni farmaceutiche

Also Published As

Publication number Publication date
WO2009126301A2 (en) 2009-10-15
EP2274015A2 (en) 2011-01-19
EA201071166A1 (ru) 2011-06-30
JP2011516548A (ja) 2011-05-26
WO2009126301A3 (en) 2010-02-18
AU2009234384A1 (en) 2009-10-15
CA2720755A1 (en) 2009-10-15
IL208481A0 (en) 2010-12-30
AU2009234384A8 (en) 2010-11-18
CN102026663A (zh) 2011-04-20
US20110081386A1 (en) 2011-04-07
KR20100135260A (ko) 2010-12-24
NZ588441A (en) 2012-10-26
MX2010011105A (es) 2011-01-14

Similar Documents

Publication Publication Date Title
BRPI0910878A2 (pt) formulações de oleossomas de liberação controlada e acabada e método de obtenção das mesmas e de liberação de agente ativo a partir de oleossoma
CY2019031I2 (el) Αναπνευστικη απελευθερωση ενεργων παραγοντων
BRPI0920030A2 (pt) agente de oclusão do tecido
BRPI0812209A2 (pt) Partícula de liberação contendo agente de benefício
BRPI0719594A2 (pt) Partícula de liberação contendo agente de benefício
BRPI0822885A2 (pt) Implemento para cuidado oral, método para administrar um agente ativo, e, kit para cuidado oral
BRPI0917390A2 (pt) dispositivo oftálmico tendo capacidade de liberação de agente terapêutico e método de formação do mesmo
BR112013013311A2 (pt) agente terapêutico de indução de citotoxicidade
BRPI0910760A2 (pt) método para remineralizar tecido, agente remineralizador, e, kit
BRPI0907918A2 (pt) Ácidos sulfoperoxicarxílicos, sua preparação e métodos de utilizção como agentes alvejantes e antimicrobianos
BRPI0920515A2 (pt) Métodos para produzir nanopartículas de polímero e formulações de ingredientes ativos
BRPI0822920A2 (pt) Implante médico e método de implantação
BRPI0920314A2 (pt) dispositivo médico com liberação controlada de agente antibacteriano
IT1392520B1 (it) Struttura di calzatura impermeabile e traspirante
BR112013002642A2 (pt) método de preparo de um enxerto de pele e método de aplicação de enxerto de pele
BRPI0910879A2 (pt) preparação estabilizada de oleossomas, formulação acabada e método de produção das mesmas
FI20085839A0 (fi) Menetelmiä ja välineitä pehmytkudosteknologiaan
BRPI0908143A2 (pt) Agente de branqueamento e preparação externa da pele
PT2329713T (pt) Agente de controlo de doença de plantas que compreende dtagatose como ingrediente ativo, e método de controlo de doença de plantas
BR112012004451A2 (pt) formulações para o cuidado com a pele"
EP2379064A4 (en) LONG CIRCULATING NANOTEHICLES FOR THE DELAYED RELEASE OF THERAPEUTIC AGENTS
BRPI0911656A2 (pt) formulações de nanopartículas e usos das mesmas
BRPI0917358A2 (pt) formulação farmacêutica de liberação controlada e método.
BRPI0908310A2 (pt) "arranjo de disco de freio e método de formação de um arranjo de disco de freio"
BRPI0907109A2 (pt) lenço dental e método

Legal Events

Date Code Title Description
B15I Others concerning applications: loss of priority
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A E 6A ANUIDADES.

B153 Others concerning applications: republication [chapter 15.33 patent gazette]

Free format text: REPUBLICACAO DO DESPACHO 15.9 DA RPI2336 DE 13/10/2015 POR ERRO MATERIAL DO PARECER PRATICADO NESTA. SEGUE O PARECER RETIFICADO: PERDA DA PRIORIDADE US 61/071,109 DE 11/04/2008 REIVINDICADA NO PCT/US2009/002242, CONFORME AS DISPOSICOES PREVISTAS NA LEI 9.279 DE 14/05/1996 (LPI) ART. 16 7O, ITEM 28 DO ATO NORMATIVO 128/97 E NO ART. 29 DA RESOLUCAO INPI-PR 77/2013. ESTA PERDA SE DEU PELO FATO DE O DEPOSITANTE CONSTANTE DA PETICAO DE REQUERIMENTO DE ENTRADA NA FASE NACIONAL SER DISTINTO DAQUELE QUE DEPOSITOU O PEDIDO ANTERIOR CUJA PRIORIDADE E REIVINDICADA E APRESENTOU COPIA DO CORRESPONDENTE DOCUMENTO DE CESSAO EM 14/03/2012, CONTUDO O PRAZO PARA A APRESENTACAO DA CESSAO DO DIREITO DE PRIORI

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2344 DE 08-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.